Preclinical Characterization of ADCT-241, an Exatecan-Based Antibody-Drug Conjugate against PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer.

Asma Jabeen, Ben Leatherdale, Rebecca Martin, Valenti Gomez, Danilo Cucchi, Banusha Rajeenthira, Hafsah Omar, Alison Faid, Pedro L Alves, Kristina Zaitseva, Nicolas Veillard, Narinder Janghra, Veronica Ilkow, Elizabeth Horsley, Lina Baxter, Christopher Gallagher, Cecile Oblette, Paul W Hogg, Monika Lamba Saini, Lolke de Haan, Charles Britten, Chris Pickford, Patrick H van Berkel

DOI: 10.1158/1535-7163.mct-25-1241

На странице источника доступны аннотация, полный текст или сведения о том, где его прочитать.